Tempo Therapeutics

🗓 Founded 2014👥 15 employees💰 Last funded Mar 2024
Biotechnology Research🌐 tempothera.com
Website LinkedIn
Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology. Using MAP technology, Tempo is building functional tissue and organs within patients, in real time, to treat disease, and developing next-generation vaccine technologies that are shelf stable, stockpile-able, and protect against multiple diseases with a single injection. Our mission is to use MAP material technology to enable the future of medicine.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2014–2024 · investors recorded per year
201412017120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Tempo Therapeutics?
Tempo Therapeutics has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Tempo Therapeutics last raise funding?
The most recent investment in Tempo Therapeutics recorded on gritt.io was in March 2024.
When was Tempo Therapeutics founded?
Tempo Therapeutics was founded in 2014.
What industry is Tempo Therapeutics in?
Tempo Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.